Replying to @⁨themachinestops@lemmy.dbzer0.com⁩

How much is the cure/treatment for Parkinson’s worth? Or other intractable medical problems?

What about a device able to manipulate the containment field of a fusion reactor?

These are the reasons why everyone is buying the compute services - there are dozens of moonshot-grade problems that are suddenly possible to attempt. Many will fail, but whoever gets that one success will gain astronomical benefit.

Replying to @⁨CameronDev@programming.dev⁩

Generally speaking, yes, but standard LLMs now have their own built-in image recognition so we might not be too far off from LLMs being able to describe to the doctor what they should look at on an image that’s been flagged. Take a capable LLM of a few hundred billion parameters, train it on tons of medical images and such, and it might actually be helpful. Or it might not, no way to find out until tested.

Replying to @⁨Xaphanos@lemmy.world⁩

I’m aware, and I wish people were more clear about the difference, but its LLMs that are driving these insane buildouts, not the other disciplines. This article is clearly talking about the LLM “AI”, not bioinformatics or anything that may actually be fruitful.

The LLM companies like to claim they’ll solve cancer, but its all snake oil hedged on a mythical AGI popping up and fixing everything.